Immatics N.V. (IMTX)
NASDAQ: IMTX · IEX Real-Time Price · USD
12.30
-0.09 (-0.73%)
At close: Jul 26, 2024, 4:00 PM
12.41
+0.11 (0.89%)
After-hours: Jul 26, 2024, 7:03 PM EDT

Immatics Revenue

Immatics had revenue of 30.27M EUR in the quarter ending March 31, 2024, with 208.99% growth. This brings the company's revenue in the last twelve months to 74.47M, down -6.59% year-over-year. In the year 2023, Immatics had annual revenue of 54.00M, down -68.76%.

Revenue (ttm)
74.47M EUR
Revenue Growth
-6.59%
P/S Ratio
15.66
Revenue / Employee
139,196 EUR
Employees
535
Market Cap
1.27B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202354.00M-118.83M-68.76%
Dec 31, 2022172.83M138.07M397.17%
Dec 31, 202134.76M3.51M11.23%
Dec 31, 202031.25M12.80M69.40%
Dec 31, 201918.45M14.68M389.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owens & Minor 10.42B
Xencor 162.18M
Ardelyx 159.11M
Establishment Labs Holdings 155.79M
Gyre Therapeutics 140.62M
Prothena Corporation 89.25M
Ocular Therapeutix 59.84M
Relay Therapeutics 35.33M
Revenue Rankings